Load mobile navigation

Andrew and Linda Leaver

Andrew Leaver formed Staffordshire pharmaceuticals company Clinigen in 2010. When Clinigen was floated on the AIM market for £135m in September 2012, Andrew and Linda sold shares for £37m - and they retained a £47 million stake in the group.

This website uses cookies. Using this website means you are okay with this but you can find out more and learn how to manage your cookie choices here.Close cookie policy overlay